Loading...
Cerus Corporation
CERS•NASDAQ
Healthcare
Medical - Devices
$1.39
$0.02(1.84%)
Cerus Corporation (CERS) Financial Performance & Income Statement Overview
Review Cerus Corporation’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
15.29%
↑ 15.29%
Operating Income Growth
52.67%
↑ 52.67%
Net Income Growth
44.20%
↑ 44.20%
Operating Cash Flow Growth
126.31%
↑ 126.31%
Operating Margin
-9.47%
↓ 9.47%
Gross Margin
56.00%
↑ 56.00%
Net Profit Margin
-10.23%
↓ 10.23%
ROE
-35.31%
↓ 35.31%
ROIC
-12.79%
↓ 12.79%
Cerus Corporation (CERS) Income Statement & Financial Overview
Review Cerus Corporation's (CERS) income statement with detailed quarterly and annual figures.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $50.81M | $46.02M | $45.08M | $38.37M |
| Cost of Revenue | $23.42M | $19.82M | $20.41M | $17.09M |
| Gross Profit | $27.39M | $26.20M | $24.67M | $21.27M |
| Gross Profit Ratio | $0.54 | $0.57 | $0.55 | $0.55 |
| R&D Expenses | $15.44M | $14.01M | $14.97M | $14.48M |
| SG&A Expenses | $19.33M | $17.79M | $18.97M | $19.80M |
| Operating Expenses | $28.83M | $31.80M | $33.94M | $34.28M |
| Total Costs & Expenses | $58.20M | $51.62M | $54.35M | $51.37M |
| Interest Income | $0.00 | $0.00 | $0.00 | $0.00 |
| Interest Expense | $2.05M | $2.26M | $2.33M | $2.23M |
| Depreciation & Amortization | $332000.00 | $412000.00 | $480000.00 | $631000.00 |
| EBITDA | -$66000.00 | -$186000.00 | -$3.02M | -$6.75M |
| EBITDA Ratio | -$0.001 | -$0.004 | -$0.07 | -$0.18 |
| Operating Income | -$1.45M | -$961000.00 | -$9.28M | -$13.009M |
| Operating Income Ratio | -$0.03 | -$0.02 | -$0.21 | -$0.34 |
| Other Income/Expenses (Net) | -$1.002M | -$1.90M | -$2.00M | -$1.64M |
| Income Before Tax | -$2.45M | -$2.86M | -$5.83M | -$9.62M |
| Income Before Tax Ratio | -$0.05 | -$0.06 | -$0.13 | -$0.25 |
| Income Tax Expense | $111000.00 | $76000.00 | -$56000.00 | $74000.00 |
| Net Income | -$2.52M | -$2.93M | -$5.78M | -$9.69M |
| Net Income Ratio | -$0.05 | -$0.06 | -$0.13 | -$0.25 |
| EPS | -$0.01 | -$0.02 | -$0.03 | -$0.05 |
| Diluted EPS | -$0.01 | -$0.02 | -$0.03 | -$0.05 |
| Weighted Avg Shares Outstanding | $185.73M | $185.42M | $184.98M | $182.09M |
| Weighted Avg Shares Outstanding (Diluted) | $185.73M | $185.42M | $184.98M | $182.09M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan